EFFECTS OF PROBENECID ON ENPROFYLLINE KINETICS IN MAN

被引：26

作者：

BORGA, O

LARSSON, R

LUNELL, E

机构：

[1] AB DRACO, PHARMACOKINET LAB, POB 34, S-22100 LUND, SWEDEN

[2] LINKOPING UNIV HOSP, DEPT NEPHROL, S-58185 LINKOPING, SWEDEN

[3] UNIV LUND HOSP, DEPT CLIN PHARMACOL, S-22185 LUND, SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 30卷 / 02期

关键词：

D O I：

10.1007/BF00614308

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：221 / 223

页数：3

共 13 条

[1] RENAL ELIMINATION OF CEFOXITIN AND EFFECT OF PROBENECID AFTER SINGLE AND REPEATED DOSES [J].

ARVIDSSON, A ;

BORGA, O ;

KAGER, L ;

PIEPER, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 7 (04) :423-430

[2] ENPROFYLLINE KINETICS IN HEALTHY-SUBJECTS AFTER SINGLE DOSES [J].

BORGA, O ;

ANDERSSON, KE ;

EDHOLM, LE ;

FAGERSTROM, PO ;

LUNELL, E ;

PERSSON, CG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (06) :799-804

[3]

GIBALDI M, 1970, Internationale Zeitschrift fuer Klinische Pharmakologie Therapie und Toxikologie, V3, P182

[4] RENAL CLEARANCE OF THEOPHYLLINE IN MAN [J].

LEVY, G ;

KOYSOOKO, R .

JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (07) :329-332

[5] PHARMACOKINETICS OF ENPROFYLLINE IN PATIENTS WITH IMPAIRED RENAL-FUNCTION AFTER A SINGLE INTRAVENOUS DOSE [J].

LUNELL, E ;

BORGA, O ;

LARSSON, R .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (01) :87-93

[6] EFFECTS OF ENPROFYLLINE, A XANTHINE LACKING ADENOSINE RECEPTOR ANTAGONISM, IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG-DISEASE [J].

LUNELL, E ;

SVEDMYR, N ;

ANDERSSON, KE ;

PERSSON, CGA .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (05) :395-402

[7] EFFECT OF PROBENECID ON DYPHYLLINE ELIMINATION [J].

MAY, DC ;

JARBOE, CH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :822-825

[8] TRACHEAL RELAXANT AND CARDIOSTIMULANT ACTIONS OF XANTHINES CAN BE DIFFERENTIATED FROM DIURETIC AND CNS-STIMULANT EFFECTS - ROLE OF ADENOSINE ANTAGONISM [J].

PERSSON, CGA ;

ERJEFALT, I ;

EDHOLM, LE ;

KARLSSON, JA ;

LAMM, CJ .

LIFE SCIENCES, 1982, 31 (24) :2673-2681

[9]

PERSSON CGA, 1981, ACTA PHARMACOL TOX, V49, P313

[10]

PERSSON CGA, 1981, ACTA PHARMACOL TOX, V49, P317

← 1 2 →